Highmark prior authorization criteria
Documentation packets and P2P preparation by drug—for prescribers and PA staff. Verify the current member-specific payer criteria and timing before submission.
Highmark reviews prior-authorization requests against its published medical policies — diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. The applicable product, plan terms, request type, urgency, and governing law determine the decision and appeal clocks. Confirm both in the current member-specific source and denial notice. Criteria by drug appear below.
Prior authorization criteria by drug
Each page covers Highmark's submission criteria, the documentation packet, and peer-to-peer prep for that drug.
- Adalimumab at Highmark →
- Aflibercept at Highmark →
- Apixaban at Highmark →
- Atezolizumab at Highmark →
- Atogepant at Highmark →
- Benralizumab at Highmark →
- Bevacizumab at Highmark →
- Bictegravir at Highmark →
- Buprenorphine at Highmark →
- Dapagliflozin at Highmark →
- Dulaglutide at Highmark →
- Dupilumab at Highmark →
- Eculizumab at Highmark →
- Elexacaftor Tezacaftor Ivacaftor at Highmark →
- Empagliflozin at Highmark →
- Erenumab at Highmark →
- Evolocumab at Highmark →
- Faricimab at Highmark →
- Fingolimod at Highmark →
- Fremanezumab at Highmark →
- Galcanezumab at Highmark →
- Glecaprevir Pibrentasvir at Highmark →
- Guselkumab at Highmark →
- Ibrutinib at Highmark →
- Imatinib at Highmark →
- Inclisiran at Highmark →
- Infliximab at Highmark →
- Ixekizumab at Highmark →
- Lenalidomide at Highmark →
- Liraglutide at Highmark →
- Lisdexamfetamine at Highmark →
- Mepolizumab at Highmark →
- Methylphenidate at Highmark →
- Naltrexone at Highmark →
- Natalizumab at Highmark →
- Nintedanib at Highmark →
- Nivolumab at Highmark →
- Nusinersen at Highmark →
- Ocrelizumab at Highmark →
- Ofatumumab at Highmark →
- Omalizumab at Highmark →
- Ozanimod at Highmark →
- Palbociclib at Highmark →
- Pembrolizumab at Highmark →
- Pirfenidone at Highmark →
- Ribociclib at Highmark →
- Rimegepant at Highmark →
- Risankizumab at Highmark →
- Rituximab at Highmark →
- Rivaroxaban at Highmark →
- Sacubitril Valsartan at Highmark →
- Secukinumab at Highmark →
- Semaglutide at Highmark →
- Sofosbuvir at Highmark →
- Tafamidis at Highmark →
- Tenofovir Alafenamide at Highmark →
- Tezepelumab at Highmark →
- Tirzepatide at Highmark →
- Tofacitinib at Highmark →
- Trastuzumab at Highmark →
- Upadacitinib at Highmark →
- Ustekinumab at Highmark →
Generate a Highmark PA packet
Open ApprovalHelp — generate a prior-auth packet tailored to Highmark's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com